Added to YB: 2026-05-07
Pitch date: 2026-05-04
AKAN [bearish]
Akanda Corp.
+83.13%
current return
Author Info
Fugazi Research exposes inflated valuations built on illusion — not substance. We dissect the narratives, trace the incentives, and reveal who’s really cashing in. In a market full of noise, we show what’s real behind the fugazi. Sign up for the newsletter.
Company Info
Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and telecommunication towers.
Market Cap
$7.8M
Pitch Price
$31.59
Price Target
N/A
Dividend
N/A
EV/EBITDA
-4.47
P/E
-0.01
EV/Sales
78.80
Sector
Pharmaceuticals
Category
turnaround
$AKAN: A Half-Baked Cannabis Company Where Shareholders Get Smoked
AKAN (short): Failed cannabis co shut down sole revenue source (Canmart) in Mar 2025, pivoted to Mexican telecom infrastructure (First Towers) generating ~$258K annual revenue vs ~$4.8M opex burn. $57.4M accumulated deficit, 91% of capital raised lost. $26M debt (up 7x), $1.3M cash, going concern. 6.7M registered conversion shares vs 534K float (12x overhang) from $19M toxic convertibles at 85% VWAP discount. Six reverse splits since 2023 (cumulative 1:56,340 ratio). Spent $6.7M on paid promos (4x market cap). Structure engineered for dilution loop, not operations. Zero fundamental value.
Read full article (13 min)